Contract 75H71221F28001

Roche Diabetes Care Inc · Department Of Health And Human Services · November 25, 2020

Firm Fixed PriceFull & Open CompetitionNAICS 325413IDIQ Task Order

Roche Diabetes Care Inc was awarded a federal contract by Department Of Health And Human Services (Indian Health Service) on November 25, 2020 for $2.67 million of work in in-vitro diagnostic substance manufacturing. Performance is in Phoenix, AZ. This is a task or delivery order issued under parent IDIQ 75H71221A00014. The contract has been modified 36 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 9, 2026.

Obligated to date
$2.67M
$2,674,622
Current value
$201.1K
Modifications
36
Latest January 9, 2026

Contract details

PIID
75H71221F28001
Parent IDIQ
75H71221A00014
Award type
Bpa Call
Pricing
Firm Fixed Price
Competition
Full And Open Competition
NAICS
325413 · In-Vitro Diagnostic Substance Manufacturing
Product / service
Medical And Surgical Instruments, Equipment, And Supplies
Place of performance
Phoenix, AZ
First action
November 25, 2020
Latest action
January 9, 2026

Description

DEOBLIGATE RESIDUAL FUNDS AND PERFORM CLOSE OUT DUTIES.

Modification timeline

  • January 9, 2026
    Mod P00001
    $-48.9K
  • October 30, 2025
    Mod P00001
    UNO, BIOFIRE DIAGNOSTICS, RESPIRATORY AND GASTROINTESTINAL PANELS SUPPIES, CLOSE-OUT CONTRACT AND DE-OBLIGATE EXCESS FUNDS
    $-3.6K
  • September 22, 2025
    Mod P00001
    KLM LABS INC, CUSTOM AND OVER THE COUNTER FOOT & ANKLE ORTHOTICS, WRSU, CLOSE-OUT CONTRACT AND DE-OBLIGATE EXCESS FUNDS
    $-17.9K
  • September 22, 2025
    Mod P00001
    THUNDERCLOUD OPTICAL, EYE GLASS & PRESCRIPTION LENSES, IRENE BENN, EYE DEPT, DE-OBLIGATE EXCESS FUNDS AND CLOSE-OUT CONTRACT
    $-14.0K
  • September 4, 2025
    Mod P00002
    DE-OBLIGATE RESIDUAL FUNDS AND CLOSE OUT CONTRACT
    $-8.6K
  • August 22, 2025
    Mod P00004
    DE-OBLIGATE REGISTERED NURSING SERVICES FOR PIMC - DESERT VISIONS & NEVADA SKIES
    $-0
  • August 1, 2025
    Mod P00001
    MRFS, WRSU
    $-35.5K
  • April 24, 2025
    Mod P00001
    DE-OBLIGATE AND CLOSE OUT CALL
    $-203.2K
  • December 5, 2024
    Mod P00001
    MOD-P00001 CLOSE-OUT CONTRACT AND DE-OBLIGATE EXCESS FUNDS, CEPHEID
    $-399.1K
  • September 9, 2024
    Mod P00001
    MOD-P00001, GOVERNMENT SCIENTIFIC SOURCE, CLOSE-OUT CONTRACT AND DE-OBLIGATE REMAINING FUNDS
    $-130.7K

Similar contracts

RecipientAgencyDateObligated
Roche Diagnostics CorporationDepartment Of Health And Human ServicesApril 1, 2026$313.4K
Roche Diagnostics CorporationDepartment Of Health And Human ServicesApril 1, 2026$75.2K
Sysmex America, IncDepartment Of Health And Human ServicesMarch 31, 2026$49.2K
Becton, Dickinson And CompanyDepartment Of Health And Human ServicesMarch 31, 2026$5.7K
Biomerieux IncDepartment Of Health And Human ServicesMarch 31, 2026$0
Beckman Coulter, Inc.Department Of Health And Human ServicesMarch 30, 2026$80.2K

Top contractors in NAICS 325413

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Abbott Rapid Dx North America Llc651$3.51B
2Ihealth Labs Inc.4$2.13B
3Roche Diagnostics Corporation5,604$959.60M
4Siemens Healthcare Diagnostics Inc.818$641.45M
5Cepheid3,693$639.45M
6Remel Inc.4,525$464.47M
7Access Bio, Inc.5$340.72M
8Ortho-Clinical Diagnostics, Inc1,964$227.77M
9Quidel Corp96$194.78M
10Ortho-Clinical Diagnostics Inc2,494$183.46M

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract 75H71221F28001?

Contract 75H71221F28001 is a federal contract awarded to Roche Diabetes Care Inc by Department Of Health And Human Services on November 25, 2020 for $2.67 million of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 36 times since the base award.

Who won contract 75H71221F28001?

Roche Diabetes Care Inc won contract 75H71221F28001 from Department Of Health And Human Services.

How much is contract 75H71221F28001 worth?

Contract 75H71221F28001 has obligated $2.67 million to date.